Table IV.
Comparison among thrombosis(+) patients in each group.
| SPC (n=7) | POC (n=20) | PCC (n=10) | |
|---|---|---|---|
| Age (years) | 51.1a | 62.8 | 66.1 |
| Type of cancer | |||
| Endometrioid adenocarcinoma G1/G2 (%) | 7 (100) | 3 (30) | |
| Endometrioid adenocarcinoma G3 (%) | 1 (0.5) | 1 (10) | |
| Serous adenocarcinoma (%) | 10 (50.0) | 4 (40) | |
| Clear cell carcinoma (%) | 1 (28.6) | 6 (30.0) | 1 (10) |
| Mucinous adenocarcinoma (%) | 2 (10.0) | ||
| Others (%) | 3 (15.0) | 1 (10) | |
| Stage | |||
| 1 | 1+1: 2 cases | 6 (30.0) | 2 (20) |
| 2 | 2+1: 2 cases, 1+2: 1 case | 1 (0.5) | 1 (10) |
| 3 | 3+1: 1 cases, 3+2 1 case | 6 (30.0) | 3 (30) |
| 4 | 7 (35.0) | 4 (40) | |
| BMI (kg/m2) | 23.2 | 22.5 | 22.8 |
| Nulliparity (%) | 4 (66.2) | 3 (15.0) | 2 (20) |
a
p<0.05.
For SPC patients, the stage is given as corpus cancer stage first and ovary cancer stage second. Therefore, 1+1 means corpus cancer is stage 1 (within corpus body), and ovarian cancer is stage 1 (within unilateral side). SPC, synchronous primary endometrial and ovarian cancer; POC, primary ovarian cancer; PCC, primary uterine corpus cancer.